Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|July 23, 2019
Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitorsNeetu Dayal, Clinton G Mikek, Delmis Hernandez, et al.
Experimental Hematology|February 1, 2022
Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclaxBandish Kapadia, Amol C Shetty, Dominique Bollino, et al.
The AAPS Journal|April 6, 2019
HER3-Targeted Affibodies with Optimized Formats Reduce Ovarian Cancer Progression in a Mouse Xenograft ModelJohn S Schardt, Madeleine Noonan-Shueh, Jinan M Oubaid, et al.
American Journal of Hematology|February 5, 2015
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemiaAshkan Emadi, Rawan Faramand, Brandon Carter-Cooper, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Identification of New FLT3 Inhibitors That Potently Inhibit AML Cell Lines via an Azo Click-It/Staple-It ApproachXiaochu Ma, Jie Zhou, Changhao Wang, et al.
Clinical & Experimental Metastasis|February 6, 2020
Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibitionJipei Liao, Zejia Yang, Brandon Carter-Cooper, et al.
Head & Neck|August 13, 2009
Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427Khurram Khan, Koji Araki, Daiyou Wang, et al.
Cancer Research|April 19, 2011
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in miceKrystyna M Wozniak, Kenichi Nomoto, Rena G Lapidus, et al.
Pageof 7